Cover Image

Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies

Saved in:

Bibliographic Details
Main Authors:	J. Karn (Author), B. Das (Author), C. Dobrowolski (Author), E. Scully (Author), S.G. Deeks (Author), M. Gandhi (Author), R.E. Johnston (Author)
Format:	Book
Published:	Elsevier, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir
by: J. Karn, et al.
Published: (2019)

Women undergoing reproductive aging show increased reservoir sizes associated with removal of hormonal control of HIV-1 latency by oestrogen
by: C. Dobrowolski, et al.
Published: (2019)

Visualisation of HIV reactivation from latency in primary resting memory T-cells
by: F. Kizito, et al.
Published: (2019)

Developing an in vitro model for HIV-1 latency in Tfh cells using tonsillar tissue
by: B. Luttge, et al.
Published: (2017)

OP 1.7 - 00194 Potent latency reversal enables in-depth transcriptomic analysis of the translation-competent HIV-1 reservoir
by: M. Pardons, et al.
Published: (2022)

Tissue-specific effects of latency-reversing agents on HIV transcriptional blocks in gut and blood
by: S. Telwatte, et al.
Published: (2019)

HIV antibodies as markers of HIV systemic reservoir and replication activity
by: S.M. Keating, et al.
Published: (2015)

Low viral reservoir treated individuals show unusual HIV latency distribution
by: C. Gálvez, et al.
Published: (2019)

Mobilizing NK cells for an HIV Cure: NK cells can target and kill latently HIV-1-infected primary T cells following proviral reactivation
by: M. Checkley, et al.
Published: (2017)

Immune control of HIV reservoirs and cure therapeutic strategies
by: B. Autran
Published: (2015)

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection
by: Suha Saleh, et al.
Published: (2017)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015)

Suppression of the HIV-1 reservoir with a potent Tat inhibitor
by: S. Valente, et al.
Published: (2015)

OP 8.2 - 00033 Interleukin-2 administration is a potent latency reversal agent in people with treated HIV infection
by: M. Freeman, et al.
Published: (2022)

Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: A. Ward, et al.
Published: (2017)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

OA3-1 HIV reservoir dynamics and immune responses after anti-PD-1 therapy
by: E. Scully, et al.
Published: (2017)

Identification of isoform-selective hydroxamic acid derivatives that potently reactivate HIV from latency
by: Elleard F.W. Heffern, et al.
Published: (2019)

Novel mechanisms of baricitinib to block reservoir seeding and HIV persistence
by: J. Kohler, et al.
Published: (2017)

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure
by: Michaela Madlenakova, et al.
Published: (2017)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
by: Quinten Debrabander, et al.
Published: (2023)

O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: Adam Ward, et al.
Published: (2017)

Mannosylated PAMAM G2 dendrimers mediated rate programmed delivery of efavirenz target HIV viral latency at reservoirs
by: Rohini Kharwade, et al.
Published: (2024)

Gut and blood differ in mechanisms governing HIV transcription/latency
by: S. Telwatte, et al.
Published: (2017)

Histone lysine methyltransferases selectively restrict HIV in central memory T cells
by: C. Dobrowolski, et al.
Published: (2017)

32 Plasmacytoid DCs control HIV latency in resting T cells by type I IFNα
by: R.M. Van der Sluis, et al.
Published: (2017)

PP 1.10 - 00069 Isotretinoin enhances IL-15 mediated HIV latency reversal and reduces the inducible latent reservoir
by: J. Howard, et al.
Published: (2022)

Re-examining the HIV 'functional cure' oxymoron: Time for precise terminology?
by: Karine Dubé, et al.
Published: (2020)

PP 1.3 - 00022 Signaling pathways that activate P-TEFb to reverse HIV latency in CD4+ T cells
by: U. Mbonye, et al.
Published: (2022)

Highlights from the HIV Cure and Reservoir Symposium, 11-12 September 2017, Ghent, Belgium
by: Sam Kint, et al.
Published: (2018)

The steroid receptor coactivators are targets for reactivation of HIV latency
by: B.C. Nikolai, et al.
Published: (2015)

PP 1.11 - 00075 Selective nuclear retention of spliced and unspliced HIV-1 mRNAs following latency reversal
by: E. Honeycutt, et al.
Published: (2022)

PP 2.13 - 00160 Enhancing Tolerability and Efficacy of Latency Reversing Agents in "Kick and Kill" HIV Cure Approaches
by: J. Moran, et al.
Published: (2022)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

Human galectin-9 is a potent mediator of HIV transcription and reactivation
by: M. Abdel-Mohsen, et al.
Published: (2015)

Efforts to eliminate the latent reservoir in resting CD4+ T cells: strategies for curing HIV-1 infection
by: Ya-Chi Ho, et al.
Published: (2015)

Neutraplex nanoparticles to target HIV reservoirs
by: C. Lavigne, et al.
Published: (2015)

Utilising genetic barcodes to understand the role of silent integration in HIV latency
by: E. Larragoite, et al.
Published: (2019)

Using barcoded HIV-1 to understand inducibility of the latent HIV-1 reservoir
by: E. Larragoite, et al.
Published: (2017)